A significant number of prostate cancer patients are treated with a combination of radiation and chemotherapy, according to Sri Sridhar, Distinguished Professor of Physics in the College of Science.
While combination therapy can have a synergistic effect, the approach has drawbacks, said Sridhar’s colleague, Paul Nguyen, an assistant professor of radiation oncology at Harvard Medical School. “Both of these are limited by the collateral damage they cause to the rest of the body,” he explained.
Full article: http://www.northeastern.edu/news/2012/04/sri-sridhar/
Physics